Pharmaceutical intermediates form the foundation of modern drug development, bridging the gap between basic chemical compounds and high-value Active Pharmaceutical Ingredients (APIs). Leveraging over five decades of expertise in pharmaceuticals and fine chemicals, Zhejiang Haizhou Pharmaceutical has developed a comprehensive portfolio of key intermediates, including 5-Aminoisophthalic Acid, 5-Amino-2,4,6-triiodoisophthaloyl Dichloride, Iohexol N-1, Ioversol N-1, Cyclen, DOTA, 1,4,7,10-Tetrabenzylcyclen, and chiral building blocks such as L-tert-Leucine and N-BOC-L-tert-Leucine. These products serve critical roles in the synthesis of contrast media, specialty APIs, and advanced pharmaceutical formulations. Supported by cGMP-compliant facilities, robust quality systems, and custom manufacturing capabilities, Haizhou Pharm delivers reliable intermediate solutions that help pharmaceutical partners accelerate development, optimize production efficiency, and ensure consistent product quality for global markets.